Open AccessEffects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction
Author(s) -
Takara L. Stanley,
Julian Falutz,
JeanClaude Mamputu,
Graziella Soulban,
Diane Potvin,
Steven Grinspoon
Publication year - 2011
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328347f3f1
Subject(s) - adiponectin , medicine , adipose tissue , endocrinology , plasminogen activator , placebo , t plasminogen activator , antigen , plasminogen activator inhibitor 1 , c reactive protein , insulin , immunology , insulin resistance , inflammation , pathology , alternative medicine
To report the effects of tesamorelin, a growth hormone-releasing hormone analogue, on inflammatory and fibrinolytic markers and to relate these effects to changes in visceral adipose tissue (VAT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom